MAPT and Alzheimer disease: Conversely, elevated levels of trimethylamine-N-oxide (TMAO), a metabolite produced by microbial metabolism of dietary choline and L-carnitine, are associated with vascular dysfunction, mitochondrial stress, BBB disruption, and tau and Aβ pathology, thereby contributing to cognitive decline and AD progression [12,27,30].